NeuroPace NPCE
NASDAQ NPCE
$12.70 -0.45 (-3.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

NeuroPace (NPCE) Income from Discontinued Operations (2025)

Updated

NeuroPace (NPCE) recorded Income from Discontinued Operations of $1.37 million in Q2 2025.

Analysis

NeuroPace (NPCE) Income from Discontinued Operations (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -74.00 Mn
10 NeuroPace 435.39 Mn 208.64 Mn 18.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.37 Mn
API Access

NeuroPace Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=NPCE&period=max&api_key=YOUR_API_KEY